Delivery Order SPE2DB24D8002-SPE2DB24FJMTY

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Jardiance 25 mg tablets over a period ending on November 5, 2024, with a ceiling value of $2,216.62. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. This IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,076.98, is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical's ECAT Generation V Program, which has...
This is a $9,135.66 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication, to support the DLA Troop Support Medical's medical supply chain operations. This delivery order is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 90 tablets of the prescription medication Jardiance 10 mg. The contract has a ceiling value of $4,835.60 and a performance period that runs through October 17, 2024. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $14,001.99, is for the delivery of the pharmaceutical product JARDIANCE 25 MG TABLET 90S. The contract has a period of performance through November 14, 2024 and is not a set-aside award. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,094.61 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Jardiance 25 mg tablets. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $27,657.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets over a performance period ending on November 20, 2024. The contract was not set aside for any specific business category. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $16,111.10, is for the delivery of the pharmaceutical product Jardiance 25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of November 22, 2023. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This award is a Delivery Order contract valued at $3,052.83, issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication. This order is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMTY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The total ceiling value of the contract is $3,984.67, with an ultimate completion date of August 20, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA, valued at $999,999,999.00, which allows the company to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. The contract does not have a set-aside designation.

Generated 11/18/24, 9:48 AM